Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Recruiting 4Terminated 3Unknown 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Conization × Clear all
NCT06351228 2024-04-08

Eternity

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Unknown
400 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02624531 2021-01-07

SYSUGO-005

Sun Yat-sen University

Phase NA Unknown
60 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡